Lisinopril and Carvedilol Reduce Cardiotoxicity in HER2+ Breast Cancer

Lisinopril and carvedilol reduced cardiotoxicity in patients with HER2-positive breast cancer treated with trastuzumab and anthracyclines.

Source: CancerNetwork - March 13, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer News Source Type: news